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ABSTRACT 
Multifunctional mesoporous silica nanoparticles (MSN) have attracted substantial attention 
with regard to their high potential for targeted drug delivery. For future clinical applications it 
is crucial to address safety concerns and understand the potential immunotoxicity of these 
nanoparticles. In this study, we assess the biocompatibility and functionality of multifunctional 
MSN in freshly isolated, primary murine immune cells. We show that the functionalized silica 
nanoparticles are rapidly and efficiently taken up into the endosomal compartment by 
specialized antigen-presenting cells such as dendritic cells. The silica nanoparticles showed 
a favorable toxicity profile and did not affect the viability of primary immune cells from the 
spleen in relevant concentrations. Cargo-free MSN induced only very low immune responses 
in primary cells as determined by surface expression of activation markers and release of 
pro-inflammatory cytokines such as Interleukin-6, -12 and -1β. In contrast, when surface-
functionalized MSN with a pH-responsive polymer capping were loaded with an immune-
activating drug, the synthetic Toll-like receptor 7 agonist R848, a strong immune response 
was provoked. We thus demonstrate that MSN represent an efficient drug delivery vehicle to 
primary immune cells that is both non-toxic and non-inflammagenic, which is a prerequisite 
for the use of these particles in biomedical applications. 
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INTRODUCTION 
In recent years the development of nanoparticles for various biomedical applications has 
been the focus of intense research.1 Rationally designed nanoparticles are engineered for 
targeted delivery of various drugs or vaccines.2 With spatio-temporally controlled release of 
their therapeutic cargo, such nanoparticles have the potential to increase drug efficacy while 
minimizing undesired off-target effects. However, due to their nanoscale size, chemical 
composition and surface reactivity, nanoparticles can be potentially detected by and interact 
with the host immune response.3 While in certain applications (e.g. vaccine delivery) an 
immunostimulatory function may be desirable,4 uncontrolled systemic immune activation will 
limit their therapeutic use. Thus, the profound understanding of a nanomaterial’s interaction 
with the immune system and its possible stimulatory and suppressive actions are a critical 
prerequisite for any clinical application. 
 
Specialized antigen-presenting cells (APC) of the innate immune system, such as dendritic 
cells (DC), constantly sample their surroundings, taking up cell debris and foreign materials. 
These cells are equipped with a variety of pattern-recognition receptors that allow for the 
detection of invading pathogens or signs of cell stress and damage.  Ligation of these 
receptors results in maturation of APCs associated with expression of costimulatory 
molecules (such as CD80 and CD86), the release of proinflammatory cytokines and 
eventually the initiation of a subsequent adaptive immune response.5 DCs have been shown 
to efficiently engulf various kinds of nanoparticles both in vitro and in vivo,6,7 but the 
consequences with regard to subsequent immune responses remain poorly understood.  
 
Previous work of some of us has been focused on the development of a portfolio of core-
shell colloidal mesoporous silica nanoparticles.8, 9 Due to their different molecular 
functionalization in the core and the shell, the MSN can be equipped with internal 
functionality for controlled host-guest interactions, a system for accurate cargo release upon 
external stimuli, as well as targeting ligands towards the required type of cell. A broad variety 
of different triggered-release capping systems were presented in the past years, based on 
external stimuli such as light10, 11, heat,12 or magnetic fields,13 or triggered by intracellular 
events including a change in pH,14, 15 redox reactions,16 or the presence of enzymes.17 For 
example,  we recently reported a multifunctional system based on a pH-responsive polymer 
(poly(2-vinylpyridine), MSN-PVP) that allows for the facile delivery of membrane-permeable 
cargos into cancer cells.18 With the possibility to integrate almost any functionality of interest, 
as well as the efficient synthesis, this system holds promise for wide-ranging biological and 
medical applications, especially in cancer therapy.  
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In this study, we investigate the immune-modulatory properties of MSN in primary murine 
splenocytes. We show that MSN themselves provoke only a marginal immune response but 
when loaded with a synthetic immune activator can function as an efficient delivery tool for 
potent immune activation. 
 
 
METHODS 
Materials. All reagents were purchased from commercial suppliers. Tetraethyl orthosilicate 
(TEOS, Sigma-Aldrich, >98%), cetyltrimethylammonium chloride (CTAC, Fluka, 25wt% in 
H2O), triethanolamine (TEA, Sigma-Aldrich, 98%), (3-aminopropyl)-triethoxysilane (APTES, 
Fluka, 95%), N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC, Sigma-
Aldrich, 97%), ammonium nitrate (Sigma-Aldrich, 99%), conc. hydrochloric acid (Sigma-
Aldrich, >95%, 37 wt%),  α-amino-ω-carboxy terminated poly(2-vinylpyridine) (NH2-PVP-
COOH, Polymer Source, Mn = 10.000, PDI = 1.08), Boc anhydride (Aldrich, 95%), N-
hydroxysulfosuccinimide sodium salt (sulfo-NHS, Sigma-Aldrich, 98%), ethanol (EtOH, 
Sigma-Aldrich, >99.5%), tetrahydrofuran (THF, anhydrous, Sigma-Aldrich, ≥99.9%), 
trifluoroacetic acid (TFA, Acros Organics, 99%), magnesium sulfate (MgSO4, anhydrous, 
Sigma-Aldrich, ≥99.5%), triethylamine (Sigma-Aldrich, ≥99%), fluorescein isothiocyanate 
(FITC, Fluka, >90%), saline-sodium citrate buffer concentrate (SSC-buffer (20x), Sigma-
Aldrich), citric acid buffer solution (citric acid/HCl/NaCl buffer, pH 2, Sigma-Aldrich), TLR7 
agonist R848 (Invivogen, Toulouse). All chemicals were used as received without further 
purification. Doubly distilled water from a Millipore system (Milli-Q Academic A10) was used 
for all synthesis and purification steps. 
 
Preparation of shell-functionalized colloidal mesoporous silica nanoparticles. Polymer-
capped mesoporous silica nanoparticles (MSN-PVP) were synthesized as described 
previously.8, 18 In brief, colloidal MSN with an amino-functionality (MSN-NH2) were prepared 
by a delayed co-condensation approach with cetyltrimethylammonium chloride (CTAC) as 
structure directing agent and tetraethylorthosilicate (TEOS) as primary silica source.8 In order 
to introduce the outer shell functionalization, 3-aminotriethoxysilane (APTES) was added 
during the condensation process. The synthesis was followed by a facile extraction of the 
organic template from the mesopores. Then, 50 mg of the template-extracted MSN-NH2 were 
subsequently reacted with a boc-protected bi-functional polymer (COOH-PVP-NHboc) 
dissolved in THF in an EDC-assisted amidation reaction. The reaction was followed by the 
deprotection of the polymer with trifluoroacetic acid, yielding the sample MSN-PVP.18 
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Fluorescein labeling of the MSN. Fluorescein isothiocyanate (FITC)-labeling of MSN-NH2 
was performed following a described procedure.19 In brief, 50 mg of MSN-NH2 dispersed in 
ethanol (25 mL) were added to an ethanolic solution of FITC (25 mL, containing 7.4 mg 
FITC, 0.19 mmol). The suspension was stirred at ambient temperature in the dark for 24 h. 
The resulting sample MSN-FITC was collected by centrifugation (19.000 rpm, 43.146 RCF, 
20 min) and washed three times with ethanol (25 mL each) by subsequent centrifugation and 
redispersion. After the final centrifugation step the particles were resuspended in absolute 
ethanol. For cell experiments, 1 mg of the labeled MSN were centrifuged and resuspended in 
1 mL phosphate-buffered saline (PBS).  
 
MSN loading with the synthetic TLR7 agonist R848. 1 mg MSN-PVP were dispersed in 
240 µL of sterile water. To open the pores and enable the uptake of the respective drug 
molecule, 50 µL of citrate buffer (pH 2) was added, followed by the addition of 10 µL R848 of 
the stock solution (1 mg/mL), yielding an overall drug concentration of 10 µg/300 µL in the 
solution. The particles were stirred overnight, centrifuged, and re-dispersed in 700 µL SSC 
buffer (pH 7) to enable the closure mechanism of the pH-responsible polymer. The resulting 
particles were washed extensively with SSC buffer (pH 7) and finally redispersed in 1 mL 
SSC. For incubation with primary cells, MSN were centrifuged and redissolved in complete 
RPMI medium (see below).  
 
Characterization of MSN. Centrifugation was performed using a Sorvall Evolution RC 
equipped with a SS-34 rotor or an Eppendorf centrifuge 5418 for small volumes. All samples 
were investigated with an FEI Titan 80-300 transmission electron microscope operating at 
300 kV with a high-angle annular dark field detector. A droplet of the diluted MSN solution in 
absolute ethanol was dried on a carbon-coated copper grid. Nitrogen sorption measurements 
were performed on a Quantachrome Instruments NOVA 4000e. All samples (15 mg each) 
were heated to 60 °C for 12 h in vacuum (10 mTorr) to outgas the samples before nitrogen 
sorption was measured at 77 K. Pore size and pore volume were calculated by a NLDFT 
equilibrium model of N2 on silica, based on the desorption branch of the isotherms. In order 
to remove the contribution of the interparticle textural porosity, pore volumes were calculated 
only up to a pore size of 8 nm. A BET model was applied in the range of 0.05 – 0.20 p/p0 to 
evaluate the specific surface area of the samples. Dynamic light scattering (DLS) 
measurements were performed on a Malvern Zetasizer-Nano instrument equipped with a 
4 mW He-Ne laser (633 nm) and an avalanche photodiode. The hydrodynamic radius of the 
particles was determined by dynamic light scattering in ethanolic or aqueous suspension. For 
this purpose, 100 µL of an ethanolic suspension of MSN particles (ca. 10 mg/mL) was diluted 
with 3 mL of ethanol or water prior to the measurement. Zeta potential measurements of the 
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samples were performed on a Malvern Zetasizer-Nano instrument equipped with a 4 mW He-
Ne laser (633 nm) and an avalanche photodiode. Zeta potential measurements were 
performed using the add-on Zetasizer titration system (MPT-2) based on diluted NaOH and 
HCl as titrants. For this purpose, 1 mg of the particles was diluted in 10 mL bi-distilled water. 
Thermogravimetric analysis was performed on a Netzsch STA 440 C TG/DSC with a heating 
rate of 10 K / min in a stream of synthetic air of about 25 mL/min. The mass was normalized 
to 100% at 150 °C for all samples to take into account solvent desorption.  
 
Mice. Female C57Bl/6 mice were purchased from Harlan-Winkelmann. Mice were at 6-8 
weeks of age at the time of the experiment. Animal studies were approved by the local 
regulatory agency (Regierung von Oberbayern, Munich, Germany). 
 
Media, reagents and cell culture. Single cell suspensions from spleens were obtained by 
filtering through a 100 µm cell strainer (BD Biosciences, Heidelberg, Germany). Erythrocytes 
were lysed with ammonium chloride buffer (BD Biosciences). Cells were cultured in complete 
RPMI (Roswell Park Memorial Institute) 1640 medium (10% fetal calf serum (FCS), 2 mM 
L-glutamine, 100 µg/mL streptomycin and 1 IU/mL penicillin) at 37 °C in 10% CO2. In some 
conditions, CpG 1826 (unmethylated CpG sequence-containing oligonucleotides, a TLR9 
agonist, 3 µg/mL, from Invivogen, Toulouse, France) was added to the culture. For maximal 
IL-1β release, DCs were primed with lipopolysaccharide (LPS, a TLR4 agonist, 20 ng/ml, 
from Invivogen) overnight and ATP (5 mM, from Sigma-Aldrich) was added to the culture 
2 hours prior to the analysis. For exposure to nanoparticles, splenocytes were seeded in 
complete RMPI at a density of 1.0 x 106 / mL in 96-well tissue culture plates. Silica 
nanoparticles were added in complete RPMI medium at the indicated concentration. After 18 
- 24 hours, cells and culture supernatant were analyzed.  
 
Quantification of cytokines. Cell supernatants were analyzed for cytokine secretion by 
ELISA (R&D Systems or eBioscience) according to the manufacturers’ protocol. 
 
Flow cytometry and apoptosis assay. Cell suspensions were stained in PBS with 1% FCS.  
Fluorochrome-coupled antibodies against the surface antigens B220, CD3, CD4, CD8, 
CD11b, CD11c, CD69, CD80, F4/80 and appropriate isotype controls were purchased from 
BioLegend. Data were acquired on a FACSCanto II (BD Biosciences) and analyzed using 
FlowJo software (Tree Star, Ashland, OR). The Annexin V-FITC Apoptosis Detection KIT 1 
(BD Biosciences) was used for detection of apoptotic cells. Following surface staining and 2 
washing steps, single-cell suspensions were resuspended in the provided buffer, incubated 
with Annexin V - FITC and propidium iodide (PI) and subsequently analyzed by flow 
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cytometry. Terminal deoxynucleotidyltransferase dUTP nick end labeling (TUNEL staining) 
was done with the APO-BRDU™ Kit (BD Pharmingen) according to the manufacturer’s 
protocol. 
 
Confocal Microscopy. Splenocytes were incubated for 4 hours with fluorescein-tagged 
NPs, washed and re-suspended in culture medium. 75 nM LysoTracker (Invitrogen) and 
3  µg/mL Hoechst dye (Invitrogen) were used for lysosomal and nuclear staining. Stained 
cells were visualized using a confocal laser scanning microscope (TCS SP5II, Leica). 
 
Statistics. All data are presented as mean ± S.E.M. Statistical significance of single 
experimental findings was assessed with the independent two-tailed Student’s t-test. For 
multiple statistical comparison of a data set the one-way ANOVA test with Bonferroni 
post-test was used. Significance was set at p-values p < 0.05, p < 0.01 and p < 0.001 and 
was then indicated with an asterisk (*, ** and ***). All statistical calculations were performed 
using Graphpad Prism (GraphPad Software). 
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RESULTS 
MSN particle characteristics. 
As reported previously,18 the template-free MSN-NH2 show a wormlike pore structure with an 
average pore size of 3.8 nm and feature a large surface area (1097 m2/g) which is typical for 
MSN (Table 1 and Fig. 1).  
 
Figure 1: Structure of mesoporous silica nanoparticles. (A) Transmission electron micrograph of a 
template-extracted MSN-NH2, exhibiting a worm-like pore structure. (B) Schematic illustration of the 
pH-responsive nanocarrier system (MSN-PVP) employed in this work at a pH value of 5 (open state). 
The inorganic-organic hybrid material consists of a mesoporous silica core (grey) and a covalently 
attached pH-responsive polymer (poly(2-vinylpyridine), blue). 
 
The covalent modification of MSN-NH2 with a boc-protected poly(2-vinylpyridine) and the 
following de-protection was monitored with several characterization methods; the accessible 
pore size as determined by nitrogen sorption measurements is barely affected by the surface 
modification with the pH-responsive polymer, whereas the decrease of the specific surface 
area is relatively large. This can be explained by the addition of non-porous polymer to the 
outer surface and the blocking of some pores by frozen polymer on the surface layer of the 
MSN. Dynamic light scattering (DLS) measurements in aqueous media revealed an average 
particle size of 160 nm for MSN-NH2 and 550 nm for MSN-PVP. The polymer-modified 
sample shows some aggregation behaviour in water due to the hydrophobicity at pH 7, 
indicated by the apparent size increase to 550 nm. However, transmission electron 
microscopy (TEM) revealed that the polymer-functionalized sample MSN-PVP still features a 
narrow particle size distribution, which makes them excellent candidates as drug delivery 
vehicles. 
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Table 1. Key features of pH-responsive MSN-PVP.  
Sample Particle size
a 
[nm] 
BET surface area 
[m²/g] 
Pore sizeb  
[nm] 
Relative mass lossc 
[%] 
MSN-NH2 160 1097 3.8 15 
MSN-PVP-NH2 550 617 3.4 62 
a) Particle size refers to the peak value derived from dynamic light scattering (DLS). b) Non-linear 
density functional theory (NLDFT) pore size refers to the peak value of the pore size distribution. c) 
Relative mass loss obtained by thermogravimetric analysis (TGA). All curves were normalized to 
150 °C.18 
 
Efficient uptake of mesoporous silica nanoparticles by specialized antigen-presenting 
cells  
To test whether MSN-NH2 can serve as a delivery tool in primary immune cells, freshly 
isolated mouse splenocytes that harbor a variety of different immune cells were cultured in 
the presence of fluorescently-labeled MSN (MSN-FITC) overnight. The uptake of labeled 
MSN-FITC by different cell types was analyzed by flow cytometry. Cells of the innate immune 
system, that includes macrophages and dendritic cells, showed high uptake of MSN-FITC, as 
measured by fluorescence signal-positive cells (Fig. 2A). As such, dendritic cells, which are 
highly specialized in antigen uptake, processing and presentation, were more efficient in 
uptake than macrophages. In contrast, T and B cells, which are the effector cells of the 
adaptive immune system, showed only trace fluorescence signal positivity. The intracellular 
uptake of MSN-FITC was clearly concentration-dependent (Fig. 2B). Fluorescent microscopy 
showed a speckled distribution pattern of fluorescent signals within dendritic cells, 
suggesting uptake of labeled MSN into distinct intracellular compartments but not into the 
cytosol or nucleus (Fig. 2C). Indeed, counter-staining with a fluorescent marker for lyso-
/endosomes showed co-localization with the fluorescein-labeled MSN. In summary, MSN 
show rapid and efficient uptake into the endosomal compartment of specialized antigen-
presenting cells such as dendritic cells but not into adaptive immune cells. 
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Figure 2: Mesoporous silica nanoparticles are efficiently taken up by specialized antigen-
presenting cells. (A, B) Freshly isolated, total splenocytes were incubated for 18 h with different 
concentrations of fluorescein-labeled MSN (MSN-FITC). The uptake of fluorescence signals by 
different cell populations was determined by flow cytometry. (A) Representative histograms are gated 
on the indicated cell subset. The numbers give the percentage of fluorescein highly positive-stained 
cells. (B) Diagrams show the mean percentage of fluorescein-positive cells of triplicate samples ± 
s.e.m. An asterisk indicates comparison with unstimulated cells. (C) Complete splenocytes were 
incubated for 3 h with 0.1 µg/mL MSN-FITC. Cell endosomes were stained with LysoTracker™ and 
intracellular MSN localization was determined by fluorescence microscopy. All results are 
representative of at least two independent experiments. No stim., no stimulation. 
 
MSN-NH2 are non-toxic and do not affect the viability of splenocytes, unless used in 
very high concentrations  
We next sought to determine the cytotoxicity of MSN for primary cells. For this purpose, 
freshly isolated splenocytes were cultured in the presence of increasing concentrations of 
MSN-NH2 and 18 hours later, we performed Annexin V / propidium iodide (PI) analysis by 
flow cytometry. Annexin V binds to phosphatidylserins, which in apoptotic cells are 
translocated from the inner to the outer leaflet of the plasma membrane, and are thus 
exposed to the external cellular environment.20 PI is a small molecule that intercalates into 
double-stranded DNA and becomes fluorescent upon intercalation. PI can only reach nuclear 
DNA when the cell’s integrity is severely compromised during late apoptosis and cell death. 
The gating strategy for early and late apoptotic cells is depicted in the representative dot blot 
(Fig. 3A). MSN-NH2 showed a favorable (low) toxicity profile in primary cells and induced 
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marked apoptosis only when used in very high concentrations of 200 µg mL-1. The common 
cytotoxic chemotherapeutic drug oxaliplatin was used as a positive control. To confirm these 
data, we also performed terminal deoxynucleotidyltransferase dUTP nick end labeling 
(TUNEL). During the late phase of apoptosis endonucleases degrade the higher order 
chromatin structure into small DNA pieces. With the TUNEL assay these DNA fragments can 
be identified through addition of bromolated deoxyuridine triphosphates (Br-dUTP) to the 
3'-hydroxyl (OH) termini of double- and single-stranded DNA by the endogenous enzyme 
terminal deoxynucleotidyl transferase (TdT) and subsequent staining with an FITC-labeled 
anti-BrdU antibody. The TUNEL analysis confirmed that MSN-NH2 are non-toxic to primary 
murine splenocytes over a wide concentration range (Fig. 3B). 
 
 
Figure 3: MSN-NH2 are non-toxic and do not affect the viability of splenocytes, unless used in 
very high concentrations. Complete splenocytes were incubated for 18 h with different 
concentrations of MSN-NH2. (A) Cell integrity and viability of splenocytes as determined by propidium 
iodide (PI) exclusion and Annexin V staining was analyzed by flow cytometry. The dot blot shows the 
gating strategy of viable (PI- Annexin V-), early (PI-, Annexin V+) and late apoptotic (PI+, Annexin V+) 
cells. (B) DNA fragmentation was assessed by TUNEL assay. The histogram shows the gating 
strategy for TUNEL+ cells. All data give the mean percentage of apoptotic cells of triplicate samples ± 
s.e.m. The mean base-line level of apoptosis in the untreated control group was set as zero %. An 
asterisk indicates comparison to untreated cells. Results are representative of at least two 
independent experiments.  
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Mesoporous silica nanoparticles induce only very low immunological responses in 
primary myeloid immune cells  
As a next step, we focused on the immunological response of mammalian primary immune 
cells to cargo-free MSN. For the implementation of any nanoparticle constructs as molecular 
delivery system, it is essential to fully understand their immune-modulatory potential in order 
to tightly control the initiation of immune responses according to the therapeutic goal. Thus, 
freshly isolated splenocytes were cultured in the presence of MSN-NH2. After 24 hours, 
surface expression of the B7 family member CD80, a co-stimulatory molecule and activation 
marker, was examined on different antigen-presenting cells by flow cytometry with specific 
fluorochrome-coupled antibodies. Additionally, the concentration of the secreted pro-
inflammatory cytokines IL-6 and IL-12p70 in the culture supernatant of stimulated cells was 
quantified by enzyme-linked immunosorbent assay (ELISA). Synthetic unmethylated CpG 
sequence-containing oligonucleotides (CpG-ODN) that resemble bacterial DNA were used 
as a positive control. CpG-ODN bind to the endosomal Toll-like receptor (TLR) 9, thereby 
initiating a full-blown immune response.21 In comparison to CpG-ODN, MSN-NH2 induced 
only low levels of CD80 expression on monocytes and dendritic cells, indicating that the 
cargo-free nanoparticles barely activate immune responses (Fig. 4A). The secretion profile 
of pro-inflammatory cytokines confirmed these findings, as cells cultured with MSN-NH2 
released only low amounts of IL-6 and IL-12p70 (Fig. 4B). Crystalline silica (found in nature 
as sand or quartz) have been shown to activate a cytosolic multi-protein complex called the 
NALP3 inflammasome resulting in the release of bioactive IL-1β, a very potent pro-
inflammatory cytokine.22 In contrast, MSN-NH2 only induced trace levels of IL-1β (Fig. 4C). In 
summary, these data demonstrate that MSN-NH2 only mildly activate primary murine APCs. 
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Figure 4: Mesoporous silica nanoparticles induce only very low immunological responses in 
primary myeloid immune cells. Complete splenocytes were incubated for 18 h with different 
concentrations of MSN-NH2. (A) The surface expression of the co-stimulatory molecule CD80 on 
myeloid antigen-presenting cells was analyzed by flow cytometry. Data give the mean fluorescence 
intensity (MFI) of the indicated marker on triplicate samples ± s.e.m. The amounts of the pro-
inflammatory cytokines (B) IL-6, IL-12p70 and (C) IL-1β in the cell culture supernatant were 
determined by ELISA. Data give the mean values of triplicate samples ± s.e.m. An asterisk indicates 
comparison to unstimulated cells. All results are representative of at least two independent 
experiments. 
 
Bystander lymphoid cells are not stimulated by mesoporous silica nanoparticles  
T and B lymphocytes are the effector cells of the adaptive immune system. We have shown 
that these cell types do not efficiently take up MSN-FITC and are thus unlikely to directly 
recognize these nanoparticles (Fig. 3A,B). However, T and B cells may react to low levels of 
pro-inflammatory cytokines released by antigen-presenting cells in response to MSN. In 
order to investigate the immunostimulatory effect of MSN on such bystander lymphocytes, 
complete splenocytes (containing both antigen-presenting cells and lymphocytes) were 
cultured in the presence of MSN-NH2 and expression of the transmembrane C-type lectin 
Primary immune response to MSN 
 
14 
 
CD69, an early activation marker on B and T cells, was analyzed by flow cytometry. We 
found that neither B nor T cells showed upregulation of the activation marker CD69 (Fig. 5), 
indicating that the low-level cytokine release by antigen-presenting cells in response to 
MSN-NH2 is not sufficient for activation of bystander lymphocytes. In summary, our findings 
show that MSN-NH2 are rapidly taken up into specialized antigen-presenting cells but are 
non-toxic and only weakly immunostimulatory to primary murine immune cells.  
 
Figure 5: Mesoporous silica nanoparticles do not result in activation of bystander lymphoid 
cells. Complete splenocytes were incubated for 18 h with different concentrations of MSN-NH2. 
Expression of the activation marker CD69 on effector (A) B lymphocytes and (B) T lymphocytes was 
analyzed by flow cytometry. The representative histogram is gated on B220+ B cells and illustrates 
CD69 expression (black dotted line, unstimulated cells; red line, 1 µg/mL MSN; blue line, CpG-DNA). 
Data in the graphs give the mean values of triplicate samples ± s.e.m. An asterisk indicates 
comparison to unstimulated cells. All results are representative of at least two independent 
experiments. 
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Functionalized mesoporous silica nanoparticles are an efficient delivery tool for the 
synthetic immunostimulatory TLR7 ligand R848 
To test whether MSN can principally function as delivery tool in primary immune cells, MSN 
coated with a pH-responsive polymer (MSN-PVP) were loaded with R848. A defined amount 
of the drug was adsorbed at low pH values into the mesopores of MSN-PVP, followed by the 
subsequent closure of the polymer coat on the mesoporous nanoparticles at pH 7. Following 
internalization and shuttling into the endosome, the local acidic environment allows for re-
opening of the mesopores and release of the cargo. The low molecular weight, synthetic 
imidazoquinoline compound R848 (also called resiquimod) induces potent immune 
responses upon uptake and ligation to endosomal TLR 7.23 Indeed, we found that both 
unbound (molecules suspended in liquid) as well as MSN-PVP-encapsulated R848 induced 
activation of dendritic cells with potent upregulation of CD80 and release of pro-inflammatory 
IL-6 (Fig. 6). These data show that MSN-PVP can be used as a drug delivery tool in primary 
immune cells. A therapeutic approach to use the targeted release of MSN cargo in the 
endosome of immune cells in order to target endosomal receptors such as TLR7 with stimuli-
responsive capping mechanisms in cancer immunotherapy will be the subject of future 
studies.  
 
 
Figure 6: Mesoporous silica nanoparticles are an efficient delivery tool for the synthetic 
immunostimulatory TLR7 ligand R848. Complete splenocytes were incubated for 18 h either with 
the small molecule immunostimulant R848, cargo-free, or R848-loaded MSN-PVP, respectively. (A) 
The surface expression of the co-stimulatory molecule CD80 on dendritic cells was analyzed by flow 
cytometry. (B) The level of Interleukin-6 in the cell culture supernatant was determined by ELISA. Data 
give the mean values of triplicate samples ± s.e.m. An asterisk indicates comparison to unstimulated 
cells. All results are representative of two independent experiments. 
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DISCUSSION 
Despite intense research in the field of nanomedicine, fundamental knowledge about the 
interaction of nanomaterials with the cellular components of the host immune system 
remains scarce. We demonstrate in this work that MSN-NH2 particles are rapidly and 
efficiently taken up by specialized antigen-presenting cells (APCs) such as dendritic cells and 
macrophages and are delivered into endo-/lysosomes. Efficient uptake of MSN via 
endocytosis into non-immune cells, in particular different types of tumor cell lines, has been 
observed previously.24, 25, 26 For example, for HeLa cervical adenocarcinoma cells, Mou and 
co-workers reported a size-dependent endosomal uptake of MSN, favouring a size range of 
50 - 120 nm.27 In contrast to tumor cells, APCs are specialized to scavenge their 
environment by taking up and sampling cell debris and foreign material, and are also 
equipped with a variety of germ-line encoded immune receptors to identify invading 
microorganisms. Many of these receptors, especially several members of the family of Toll-
like receptors (TLR), are localized in the endosome and upon ligation of pathogenic material 
lead to innate immune stimulation. However, our results demonstrate that the uptake of 
cargo-free MSN-NH2 into APCs did not result in immune activation, as dendritic cells and 
macrophages showed only mild upregulation of the co-stimulatory molecule CD80 and 
released only low levels of pro-inflammatory cytokines. Similarly, Lee et al. showed that 
incubation of a macrophage cell line or peritoneal macrophages with MSN resulted in only 
trace release of cytokines and that short-term in vivo application of MSN in mice did not lead 
to contact hypersensitivity.28 However, treatment of mice with MSN over a time course of 
several weeks resulted in histological changes in liver and spleen.29 We note that such 
findings are expected to be very dependent on the size, surface functionalization and zeta 
potential of the particles and thus cannot be generalized for different types of MSN. 
Generally, the impact of repetitive treatments with MSN must be carefully evaluated before 
long-term clinical applications are conducted. 
 
Crystalline silica have been shown to potently activate the NLRP3 inflammasome, a cytosolic 
multiprotein complex, triggering the release of the bioactive form of the potent pro-
inflammatory cytokine IL-1β.30 Similar to crystalline silica, non-functionalized, amorphous 
silica nanoparticles can activate the inflammasome, leading to significant IL-1β secretion.31 In 
contrast, here we demonstrate that the molecularly functionalized MSN-NH2 particles do not 
induce relevant levels of IL-1β release from primary murine splenocytes. Initial reports 
suggested that phagocytosis of crystalline silica  with a median particle size of 5 µm results in 
presumably osmotic swelling and damage of the lysosome, leading to activation of the 
NALP3 inflammasome, which is triggered by lysosomal rupture and content release, not the 
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crystal structure itself.30 While others linked the formation of reactive oxygen species during 
an oxidative stress situation to NLRP3 activation,32 the exact molecular mechanism and 
prerequisite for inflammasome activation remains to be determined. We propose that due to 
their size and molecularly functionalized surface structure, spherical MSN-NH2 in comparison 
to silica crystals do not induce lysosomal damage and subsequent inflammasome-mediated 
IL-1β release. Generally, besides the physicochemical properties of particle size and surface 
chemistry, the biological activity of MSN has also been attributed to shape features such as 
aspect ratio and morphology.33 
 
MSN have attracted much interest for their potential as drug delivery vehicles to control 
various cell functions by the stimuli-responsive delivery of bioactive cargos.34, 35, 36 An ideal 
drug delivery vehicle based on MSN may be composed of a multifunctional silica core able to 
specifically control the interaction with diverse active cargo components. The cargo 
molecules (e.g. pharmaceutically active drugs) are adsorbed in the mesopores of the 
nanoparticles, yielding an effective shielding from external degradation in biological fluids.37, 
38 Such multi-functional MSN have been successfully evaluated as antigen carriers and 
adjuvants for vaccine delivery.39 Thereby, MSN have shown intrinsic adjuvant activity under 
certain conditions, thus potentiating antigen-specific T-cell immune responses.40,41 
Interestingly, MSN have been described to enhance MHC class I-restricted presentation of 
antigens by human dendritic cells.42 This process called cross-presentation is a vital 
prerequisite for the induction of adaptive T-cell immunity against exogenous antigens such 
as tumor proteins. We found that the functionalized MSN-NH2 without protein or adjuvant 
cargo do not interact with or activate T- and B-lymphocytes in vitro. These findings underline 
the important role of dendritic cells at the interface of innate and adaptive immunity. 
Importantly, the lack of unspecific lymphocyte priming by the MSN carrier system is a 
promising requisite for future in vivo applications in order to use the high specificity of 
molecular immunostimulants either on the surface of the MSN or delivered as cargo from its 
pore system.  
 
Generally, the application of immunostimulatory adjuvants or vaccines via MSN harbors the 
risk of undesired systemic inflammatory responses upon the uptake of cargo-loaded MSN 
and subsequent cargo release. These dangerous adverse events can possibly be 
circumvented by context-dependent, spatiotemporally controlled cargo release. We and other 
groups pursue a promising approach that takes advantage of internal triggers such as an 
intracellular change in pH.14, 15 The efficient pH-responsive closing and opening mechanism 
of a reversible polymer cap system has been previously demonstrated by time-based 
fluorescence release experiments; fluorescent dyes were used in these studies.18, 43 In this 
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work, the synthetic TLR7 agonist R848 (resiquimod) was used as active cargo. R848-loaded 
MSN-PVP particles induced strong activation of dendritic cells with potent release of pro-
inflammatory cytokines. As a defined ligand for endosomal TLR7/8, R848 was presumably 
released after pH-dependent reopening of the mesopores in the endosome. Whether such 
spatially controlled release can augment the efficacy and regulation of the subsequent 
immune response is the focus of ongoing research. Similarly, temporally defined release of 
the MSN-PVP cargo also appears attractive, as the kinetics of receptor sensitivity strongly 
influence the outcome of R848-based cancer immunotherapy.44 
 
In summary, we demonstrate in this study that MSN-NH2 nanoparticles are non-toxic to 
primary murine leukocytes and provoke only trace immune activation. In addition, surface 
functionalized MSN-PVP can serve as a pH-triggered drug delivery tool for the synthetic 
TLR7/8 ligand R848 to induce potent immune activation in responder cells. The controlled 
release of their immunomodulatory cargo by otherwise non-immunogenic MSN is a 
promising tool in future therapies in order to achieve localized immune activation (e.g. in the 
tumor microenvironment) while preventing undesired, systemic adverse effects. 
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